Delighted to share our work on behalf of @BritSocGastro Quality Standards group in collaboration with the @LiverTrust 'Development and feasibility of a patient-reported experience survey for outpatients with liver disease' in @FrontGastro_BMJ https://t.co/otZLTp9ta0

🔵 11/14 | BASL × FG Special Issue “More young people with childhood-onset liver disease are now entering adult services — preparedness is essential.” 🔄 100–150 patients transition to adult hepatology care each year in the UK 🧭 Key needs include: psychosocial assessment,

🟢 10/14 | BASL × FG Special Issue “Personalised treatment is reshaping how we manage difficult autoimmune hepatitis.” 🧬 Optimised thiopurine therapy + metabolite monitoring now standard of care 💊 MMF established as leading 2nd-line — and viable 1st-line in select cases 🧪

🤖 The robot wars have started. New platforms are moving into soft-tissue surgery fast. 🚨 Who’s winning? Who’s scalable? What’s hype vs real? Full breakdown in Frontline Gastroenterology: 🔓 https://t.co/s2Lp9ecHxl #SurgicalRobotics #MedTech #GIendoscopy #FGjournal

Looking forward to speaking at #BASL2025 tomorrow in Belfast about the #EpCOT study @basl_events 🔟 years in the making - an 🏴󠁧󠁢󠁥󠁮󠁧󠁿 registry data linkage project using @NHSBT_Stats and @NHSEngland data giving insights into post solid organ transplant cancer epidemiology. 👊🏼👊🏼👊🏼

🟣 9/14 | BASL × FG Special Issue “Malnutrition and frailty affect up to 80% of patients with decompensated cirrhosis.” ⚠️ Both double the risk of hospitalisation and mortality 🧪 Tools like LFI, DASI, MAMC & HGS enable early identification 🤝 MDT prehabilitation (nutrition,

Thanks @BASLedu for inviting me to present my work on the novel DAS score which can predict 1️⃣ACLF 2️⃣ Mortality 3️⃣ Renal dysfunction Couldn’t resist plugging the next @uk_torch project as well! #EVADE @rajmookerjee @RajivJalan1 @sheiybani @ChrisMysko @OTavabie @BSGTrainees

Delighted that our team has won the Dr Falk/BASL/BLT Service Improvement Award for our Hepatology@Home service, an extension of our Hepatology Ambulatory Unit. A huge thank you to @TamCarg for your ongoing support and commitment to this service! @OUH_Liverunit @OUHospitals

Delighted that we have helped establish the baseline performance of HCC surveillance in 🇬🇧. We hope this drives local service improvement and increases access to curative treatment for #HCC for our patients #livertwitter @SHiNEUK_study @MFT_Research @GutsCharityUK @LiverTrust

Great to see so many trainees at #basl2025! First time we have had a trainees meet & greet session at the annual meeting!

@OTavabie @tom_marjot @brennap9 @BASLedu @aelsharkawy75 @Drwenhaoli @druppygill @DebbieShawcros1 @stumcp @BritSocGastro Congratulations @brennap9. You've become a real leader in the field with thoughtful, well written studies that are important contributions to the field and to expanding the community of practice. Thank you for the close collaboration these past years.

🚨 The November issue of Frontline Gastroenterology is live! From service innovation to cutting-edge clinical practice, this issue is packed with content for gastroenterologists, trainees & the wider MDT. 🔗 Read the full issue: https://t.co/jxhLtM3BW1 #FGjournal

🟠 8/14 | BASL × FG Special Issue “Anticoagulation in cirrhosis is no longer contraindicated — evidence supports a rebalanced haemostasis model.” 🫀 AF and VTE are more common in cirrhosis — stroke/VTE risk is clinically significant 🩸 Prolonged INR & thrombocytopenia do not

Brilliant expert panel discussed hosted by Prof. Matt Armstrong and Prof. Suzanne Norris .. a vibrant discussion emphasising the importance of an MDT approach with emphasis on AHP involvement and lifestyle intervention @Drfattyliver @BASLedu #BASL2025

⁦⁦@LisaVWMD giving an exceptionally clear williamscalne lecture on CV sustainability post liver transplant at #BLTG2025 #BASL2025 ⁦@IanARowe⁩ @LiverAHPs⁩ ⁦@basl_events⁩ ⁦@basl_events⁩ @AASLDtweets⁩ ⁦@EASLedu⁩ ⁦@BTStransplant⁩ 👏👏

Prof Stuart McPherson presents on ways to improve HCC surveillance in the UK. Great to see data from @SHiNEUK_study @uk_torch helping to shape how this can be done in the future. #basl2025 @stumcp

Huge body of work! Big fan 🤩 congratulations @brennap9 👍

Thanks @PhilSmithIsBack for the shout out @BASLedu of our recent paper in @FrontGastro_BMJ https://t.co/IHnauiQCRW

A very worthy Sheila Sherlock winner - congratulations ⁦@brennap9⁩ #basl2025 ⁦@BASLedu⁩ ⁦@JVLazarus⁩ ⁦@aelsharkawy75⁩ ⁦@Drwenhaoli⁩ ⁦@druppygill⁩ ⁦@tom_marjot⁩ ⁦@DebbieShawcros1⁩ ⁦@stumcp⁩ ⁦@BritSocGastro⁩

🟤 7/14 | BASL × FG Special Issue “Treating AUD is central to managing alcohol-related liver disease — but uptake remains low.” 📉 <20% of patients with AUD + ArLD receive treatment 💊 <2% are prescribed pharmacotherapy despite proven benefit 🤝 Integrated hepatology–addiction

Dr Deepak Joshi presents on recurrent PSC post transplantation. Factors associated with higher risk of recurrent PSC post transplant include: - Recurrent cholangitis pre LT - ACR episodes - Dual immunosuppression - Poorly controlled IBD